Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Cytidine deaminase | 0.0122 | 1 | 1 |
Trypanosoma brucei | RNA helicase, putative | 0.0086 | 0.6312 | 0.6312 |
Trypanosoma cruzi | cytidine deaminase-like protein | 0.0122 | 1 | 1 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0023 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable cytidine deaminase Cdd (cytidine aminohydrolase) (cytidine nucleoside deaminase) | 0.0122 | 1 | 0.5 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0025 | 0.0195 | 0.0195 |
Toxoplasma gondii | cytidine and deoxycytidylate deaminase zinc-binding region domain-containing protein | 0.0122 | 1 | 1 |
Onchocerca volvulus | 0.0122 | 1 | 1 | |
Trypanosoma brucei | unspecified product | 0.0025 | 0.0195 | 0.0195 |
Trypanosoma brucei | cytidine deaminase | 0.0122 | 1 | 1 |
Mycobacterium ulcerans | cytidine deaminase | 0.0122 | 1 | 0.5 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0025 | 0.0195 | 0.0195 |
Onchocerca volvulus | 0.0122 | 1 | 1 | |
Entamoeba histolytica | cytidine deaminase, putative | 0.0122 | 1 | 0.5 |
Mycobacterium leprae | PROBABLE CYTIDINE DEAMINASE CDD (CYTIDINE AMINOHYDROLASE) (CYTIDINE NUCLEOSIDE DEAMINASE) | 0.0122 | 1 | 0.5 |
Echinococcus multilocularis | cytidine deaminase | 0.0122 | 1 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0025 | 0.0195 | 0.0195 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0023 | 0 | 0.5 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0025 | 0.0195 | 0.0195 |
Echinococcus granulosus | cytidine deaminase | 0.0122 | 1 | 1 |
Leishmania major | cytidine deaminase-like protein | 0.0122 | 1 | 1 |
Trichomonas vaginalis | cytidine deaminase, putative | 0.0122 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0086 | 0.6312 | 1 |
Trichomonas vaginalis | cytidine deaminase, putative | 0.0122 | 1 | 1 |
Trypanosoma cruzi | cytidine deaminase-like protein, putative | 0.0122 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.